GSA Capital Partners’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $432K | Buy |
41,602
+24,811
| +148% | +$258K | 0.03% | 1023 |
|
|
2025
Q1 | $221K | Buy |
+16,791
| New | +$221K | 0.02% | 1346 |
|
|
2024
Q1 | – | Sell |
-4,483
| Closed | -$93K | – | 1915 |
|
|
2023
Q4 | $93K | Sell |
4,483
-5,192
| -54% | -$108K | 0.01% | 1401 |
|
|
2023
Q3 | $308K | Buy |
+9,675
| New | +$308K | 0.03% | 1060 |
|
|
2023
Q2 | – | Sell |
-11,091
| Closed | -$462K | – | 1880 |
|
|
2023
Q1 | $462K | Sell |
11,091
-1,312
| -11% | -$54.7K | 0.05% | 770 |
|
|
2022
Q4 | $420K | Sell |
12,403
-11,757
| -49% | -$398K | 0.05% | 709 |
|
|
2022
Q3 | $1.19M | Sell |
24,160
-2,408
| -9% | -$119K | 0.16% | 101 |
|
|
2022
Q2 | $1.04M | Buy |
26,568
+21,518
| +426% | +$846K | 0.16% | 130 |
|
|
2022
Q1 | $186K | Buy |
+5,050
| New | +$186K | 0.03% | 1190 |
|
|
2021
Q1 | – | Sell |
-2,038
| Closed | -$185K | – | 1431 |
|
|
2020
Q4 | $185K | Buy |
+2,038
| New | +$185K | 0.03% | 1012 |
|
|
2019
Q3 | – | Sell |
-2,782
| Closed | -$149K | – | 1665 |
|
|
2019
Q2 | $149K | Sell |
2,782
-3,131
| -53% | -$168K | 0.02% | 1292 |
|
|
2019
Q1 | $420K | Buy |
+5,913
| New | +$420K | 0.04% | 799 |
|